Colgate-Palmolive (CL) Insider Sells $539,702.50 in Stock

Colgate-Palmolive (NYSE:CL) insider Jennifer Daniels sold 7,375 shares of the stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total transaction of $539,702.50. Following the completion of the sale, the insider now directly owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Colgate-Palmolive (NYSE CL) opened at $74.05 on Monday. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. The firm has a market cap of $65,023.68, a P/E ratio of 25.80, a P/E/G ratio of 3.39 and a beta of 0.81. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.73. The firm had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter last year, the company posted $0.73 EPS. analysts expect that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

Several research firms have recently weighed in on CL. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their price target for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. Societe Generale cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Citigroup dropped their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a research note on Sunday, October 29th. Finally, Royal Bank of Canada reissued a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $76.04.

Several large investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in Colgate-Palmolive by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after buying an additional 1,621,392 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in Colgate-Palmolive by 42.4% during the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after buying an additional 2,903,800 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in Colgate-Palmolive by 25.3% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after buying an additional 1,385,946 shares in the last quarter. First Eagle Investment Management LLC lifted its holdings in Colgate-Palmolive by 35.8% during the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after buying an additional 1,750,417 shares in the last quarter. Finally, Harding Loevner LP lifted its holdings in Colgate-Palmolive by 92.0% during the 3rd quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock worth $176,329,000 after buying an additional 2,272,675 shares in the last quarter. 72.96% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) Insider Sells $539,702.50 in Stock” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://sportsperspectives.com/2017/12/18/colgate-palmolive-cl-insider-sells-539702-50-in-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply